Topic prioritisation
Showing 1 to 1 of 1
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812 | None selected | n/a | TBC |